Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : Undisclosed
Deal Type : Collaboration
Flagship Announces Two New Agreements with Ampersand & Montai
Details : Under the collaboration, Montai's CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related target.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 20, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Flagship Pioneering
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?